Back to funds
View filing
Commodore Capital LP
hedge fundUpdated 27 days agoManaged by Commodore Capital Lp • Latest filing Q2 2026
Portfolio value
$1.7B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
69.6%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $656.8M |
| Q2 2023 | $889.8M |
| Q3 2023 | $855.5M |
| Q4 2023 | $1.2B |
| Q1 2024 | $1.5B |
| Q2 2024 | $1.5B |
| Q3 2024 | $1.6B |
| Q4 2024 | $1.4B |
| Q1 2025 | $1.4B |
| Q2 2025 | $1.4B |
| Q3 2025 | $2B |
| Q4 2025 | $1.5B |
| Q1 2026 | $1.7B |
| Q2 2026 | $1.7B |
Top holdings
33 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | R RLAY RELAY THERAPEUTICS INC | $224.5M | 12.00M | 13.37% | — |
| 2 | E ELVN ENLIVEN THERAPEUTICS INC | $166.2M | 3.27M | 9.90% | — |
| 3 | A ALKS ALKERMES PLC | $157.2M | 3.00M | 9.36% | — |
| 4 | C COGT COGENT BIOSCIENCES INC | $118M | 3.05M | 7.03% | — |
| 5 | A AMLX AMYLYX PHARMACEUTICALS INC | $101.5M | 5.65M | 6.04% | — |
| 6 | D DFTX DEFINIUM THERAPEUTICS INC | $94.1M | 2.00M | 5.60% | — |
| 7 | S SYRE SPYRE THERAPEUTICS INC | $75.2M | 846.8K | 4.48% | — |
| 8 | A ANRO ALTO NEUROSCIENCE INC | $71.9M | 2.72M | 4.28% | — |
| 9 | T TNGX TANGO THERAPEUTICS INC | $70.3M | 2.25M | 4.19% | — |
| 10 | ? N/A EYEPOINT INC | $65.8M | 4.60M | 3.92% | — |
| 11 | T TYRA TYRA BIOSCIENCES INC | $59.9M | 1.88M | 3.57% | — |
| 12 | ? N/A DAMORA THERAPEUTICS INC | $50.4M | 1.94M | 3.00% | — |
| 13 | C CLDX CELLDEX THERAPEUTICS INC NEW | $50.2M | 1.35M | 2.99% | — |
| 14 | P PHVS PHARVARIS N V | $49.3M | 1.43M | 2.93% | — |
| 15 | L LBRX LB PHARMACEUTICALS INC | $48.7M | 1.50M | 2.90% | — |
| 16 | A ASH ASSEMBLY BIOSCIENCES INC | $38.9M | 1.42M | 2.32% | — |
| 17 | E EIX EDITAS MEDICINE INC | $28.8M | 8.89M | 1.72% | — |
| 18 | K KYMR KYMERA THERAPEUTICS INC | $28.7M | 250.0K | 1.71% | — |
| 19 | ? N/A PERSPECTIVE THERAPEUTICS INC | $21.6M | 6.34M | 1.29% | — |
| 20 | C CRNC CENTURY THERAPEUTICS INC | $21.3M | 8.70M | 1.27% | — |